Survival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression
International Journal of Cancer, 04/20/2012
Felix AS et al. – The authors identified a unique molecular signature associated with better overall survival (OS) and recurrence–free survival (RFS) in endometrial cancer (EC) patients. In addition to pathological characteristics of the tumor, expression of CXCL12 and ER may be clinically useful for assigning adjuvant treatment to EC cases.